In Vitro Toxicity Testing Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

In Vitro Toxicity Testing helps in assessing the toxic properties of compounds and mixtures on cultured bacteria or mammalian cells and provides human pharmacokinetic and metabolic profiles. In vitro toxicity testing eliminates the use of animals from the testing procedures. Increasing prevalence of chronic disorders and rise in pandemic disease during the forecasted period is anticipated to assist the growth of the market.

Furthermore, major players in the market are focused on adopting expansion strategies such as mergers & acquisitions along strategic collaboration and partnerships to increase their product portfolio during the forecast period.

Key features of the study:

• This report provides in-depth analysis of the In Vitro Toxicity Testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global In Vitro Toxicity Testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Bio-Rad Laboratories, Inc., Cyprotex, Charles River Laboratories International Inc., and Covance Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global In Vitro Toxicity Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global In Vitro Toxicity Testing market

Detailed Segmentation:

In Vitro Toxicity Testing Market, By Type:

• Absorption
• Toxic Substances
• Dose

In Vitro Toxicity Testing Market, By End User:

• Cosmetics And Household Products
• Pharmaceutical Industry
• Food Industry
• Chemicals Industry

In Vitro Toxicity Testing Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa

Company Profiles

• Bio-Rad Laboratories, Inc. *
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Cyprotex
• Charles River Laboratories International Inc.
• Covance Inc.
• “*” marked represents similar segmentation in other categories in the respective section.